Insilico Medicine and SK Biopharmaceuticals have entered an Artificial Intelligence (AI)-powered drug discovery collaboration worth up to USD 2.5 billion to develop innovative therapies for neuroimmune disorders.
AI In Pharmaceutical Research | 23/06/2026 | By News Bureau | 413
AI-Driven Drug Discovery Workshop Held at CSIR-HRDC Ghaziabad
A three-day AI-driven drug discovery workshop at CSIR-HRDC Ghaziabad equipped CSIR scientists and technical officers with advanced tools, techniques, and applications in modern pharmaceutical research.
AI In Pharmaceutical Research | 10/04/2026 | By News Bureau | 138
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy